Auto Added by WPeMatico
Want to keep track of the largest startup funding deals in 2026 with our curated list of $100 million-plus venture deals to U.S.-based companies? Check out The Crunchbase Megadeals Board. This is a weekly feature that runs down the week’s top 10 announced funding rounds in the U.S. Check out last week’s biggest funding deal […]
Want to keep track of the largest startup funding deals in 2026 with our curated list of $100 million-plus venture deals to U.S.-based companies? Check out The Crunchbase Megadeals Board. This is a weekly feature that runs down the week’s top 10 announced funding rounds in the U.S. Check out last week’s biggest funding deal
Five cycles, three clinics, two countries and a six-figure financial toll spanning about four years. When Nader AlSalim and his wife were navigating the complex world of fertility treatment, the process was marked by stress and financial strain. But after finally achieving a successful outcome, AlSalim recognized how different his experience was from many others
Want to keep track of the largest startup funding deals in 2026 with our curated list of $100 million-plus venture deals to U.S.-based companies? Check out The Crunchbase Megadeals Board. This is a weekly feature that runs down the week’s top 10 announced funding rounds in the U.S. Check out last week’s biggest funding deal
The Week’s 10 Biggest Funding Rounds: Anduril Leads Varied Lineup Of Large Deals Read More »
Any startup CEO can talk about future plans for going public. But until a company actually files for an IPO, it’s all just speculation. We’re not talking about confidential filings either. Sure, they signal serious intent and contain valuable information for regulators. But for the rest of us, it’s the public S-1 filing that signifies
Eli Lilly announced Monday that it is acquiring Kelonia Therapeutics, a developer of gene therapies with a particular focus on cancer treatment, in a deal valued at up to $7 billion in cash. Per Crunchbase data, the high end of the purchase price represents the largest acquisition of a venture-backed biotech company in years. It’s
Lilly Acquiring Kelonia In Largest Funded Biotech Startup Purchase In Years Read More »
Eli Lilly announced Monday that it is acquiring Kelonia Therapeutics, a developer of gene therapies with a particular focus on cancer treatment, in a deal valued at up to $7 billion in cash. Per Crunchbase data, the high end of the purchase price represents the largest acquisition of a venture-backed biotech company in years. It’s
Lilly Acquiring Kelonia In Largest Funded Biotech Startup Purchase In Years Read More »
Want to keep track of the largest startup funding deals in 2025 with our curated list of $100 million-plus venture deals to U.S.-based companies? Check out The Crunchbase Megadeals Board. This is a weekly feature that runs down the week’s top 10 announced funding rounds in the U.S. Check out last week’s biggest funding deal
The Week’s 10 Biggest Funding Rounds: Transportation And Biotech Take The Lead Read More »
By Louis Blankemeier In October 2024, my co-founders and I set out to make our Ph.D. research useful in the real world. We had built AI models that could interpret medical images such as X-rays and CT scans across tens of thousands of potential diagnoses, generating comprehensive radiology reports that mirror how radiologists reason in
By Louis Blankemeier In October 2024, my co-founders and I set out to make our Ph.D. research useful in the real world. We had built AI models that could interpret medical images such as X-rays and CT scans across tens of thousands of potential diagnoses, generating comprehensive radiology reports that mirror how radiologists reason in
